The Value Signal — September 26, 2026

699 articles scanned · 14 high-signal

Signal Map

Executive Summary

The measurement layer has become the policy battleground: CMS is rewriting how quality is scored and physicians are paid, even as oversight bodies show the underlying data cannot yet bear the financial weight being placed on it.

On Medicare, Health Affairs asks bluntly what Medicare Advantage is actually buying, and warns that quality bonuses are about to reprice on data rather than medicine, so plans with the same care could earn different scores. Under MIPS, AASM flags fresh CMS updates to MIPS Value Pathways, extending specialty-specific reporting as the vehicle for clinician accountability. On the APM and CMMI front, the Commonwealth Fund argues that two new federal initiatives could change how physicians are paid, while Advisory Board notes that CMS has broadened the ACCESS model. On Risk-based Contracts and Medicaid, Fierce Healthcare reports that a new employer–clinician alliance will push for direct contracting and that 37 states have partnered with CMS to rethink Medicaid quality measures.

On Oversight, HHS OIG exposes the fragility underneath. It finds limitations in CMS's accuracy checks on state-submitted Medicaid managed care medical loss ratio data, identifies millions in Tennessee targeted case management claims that failed federal and state requirements, and highlights a $1 million Massachusetts settlement with nursing facility operator RegalCare over a Medicare and Medicaid price-hike scheme. On Prior Authorization, AAPC reports that certain DMEPOS suppliers face prior authorization changes starting in October. Meanwhile, AJMC features David Johnson, MD, MPH, on using clinical and claims data to guide care and gold carding, which signals that data-driven exemptions, not blanket rules, are the likely next phase of utilization management.